Oral Excipients

Abstract The complexity of inflammatory bowel disease (IBD) and its pharmacological management has driven research to explore novel treatment options...

Abstract There is growing demand for simplified collection of the fine particle dose (FPD, mass of particles less than 5 µm...

Abstract Despite recent advancements in the development of in vitro precipitation assays for weakly basic drugs, their relevance for predicting...

Abstract Pediatric patients are at increased risk of exposure to potentially harmful excipients when receiving off-label medicinal products primarily formulated...

Objectives of this study Multiple factors affect oral delivery of therapeutic peptides such as acidic and enzymatic degradation in the...

Abstract Snail slime, well-known for its outstanding benefits in wound healing and skin disorders, is just beginning to be investigated...

Abstract The recent advancement of 3D-printed drugs is an emerging technology that has the potential for effective and safe oral...

Abstract The development of a robust oral solid dosage form requires knowledge of all the sources of variation that could...

Abstract The taste of a drug impacts the compliance of patients for oral administration. In this study, the bitter taste...

Abstract The incorporation of poorly soluble active ingredients, which make up the majority of the molecules in development, into fixed-dose...